ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ICU Medical (ICUI) Shares Skyrocket, What You Need To Know

ICUI Cover Image

What Happened?

Shares of medical device company ICU Medical (NASDAQ: ICUI) jumped 7.7% in the afternoon session after the company reported third-quarter 2025 results that surpassed analyst expectations and provided an upbeat financial outlook. 

The medical device maker posted adjusted earnings of $2.03 per share, significantly higher than the analyst forecast of $1.43. Revenue also beat estimates, coming in at $537 million. Although sales declined by 8.9% compared to the same period last year, profitability improved, with adjusted earnings per share growing 28% year over year. Looking ahead, ICU Medical provided full-year guidance for both adjusted earnings per share and adjusted EBITDA that topped Wall Street's forecasts.

Is now the time to buy ICU Medical? Access our full analysis report here.

What Is The Market Telling Us

ICU Medical’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 28 days ago when the stock dropped 2.8% on the news that worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling a meeting with President Xi caused a rapid sell-off in the market. The trade dispute flared up after China imposed export controls on rare earth minerals, which are critical components for high-tech manufacturing. The escalation of the trade war raises concerns about supply chain disruptions and increased costs for technology companies, which are heavily reliant on global trade, leading to a broad sell-off in the sector.

ICU Medical is down 11.2% since the beginning of the year, and at $140.29 per share, it is trading 21.4% below its 52-week high of $178.55 from November 2024. Investors who bought $1,000 worth of ICU Medical’s shares 5 years ago would now be looking at an investment worth $733.65.

The biggest winners—Microsoft, Alphabet, Coca-Cola, Monster Beverage—were all riding powerful megatrends before Wall Street caught on. We’ve just identified an under-the-radar profitable growth stock positioned at the center of the AI boom. Get it FREE here before the crowd discovers it. GO HERE NOW.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.20
+0.00 (0.00%)
AAPL  273.47
+0.00 (0.00%)
AMD  258.89
+0.00 (0.00%)
BAC  54.11
+0.00 (0.00%)
GOOG  287.43
+0.00 (0.00%)
META  609.01
+0.00 (0.00%)
MSFT  511.14
+0.00 (0.00%)
NVDA  193.80
+0.00 (0.00%)
ORCL  226.99
+0.00 (0.00%)
TSLA  430.60
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.